Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment
by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was
Updated on: January 04,2024
9
Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment
by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was
Updated on:January 04,2024
9
